Mankind Pharma Limited has informed the Exchange about Schedule of meet
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mankind Pharma has disclosed that its management will participate in two investor meetings in Mumbai on June 1-2, 2026. The first is a group meeting at a Bank of America organized conference, and the second is a one-on-one/group meeting with various investors. The company clarified that no unpublished price sensitive information (UPSI) will be shared during these discussions—only publicly available information and general business outlook will be discussed. The filing notes the BofA conference was finalized at short notice, prompting the immediate disclosure. The schedule may change due to exigencies.
This is a routine investor relations disclosure with no immediate impact on the stock. It signals management engagement with institutional investors and commitment to transparency under SEBI regulations.